找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Management of Renal Tumors; Ronald M. Bukowski,Andrew C. Novick Book 2008 The Editor(s) (if applicable) and The Author(s), under

[復(fù)制鏈接]
樓主: POL
11#
發(fā)表于 2025-3-23 13:47:41 | 只看該作者
Radical Nephrectomy,, and a lymph node dissection, removing the paraaortic and paracaval nodal packets from the crus of the diaphragm superiorly to the aortic bifurcation inferiorly. Since that time, the technique of radical nephrectomy has undergone some modification, but the general principles outlined remain germane to today’s contemporary practice.
12#
發(fā)表于 2025-3-23 14:12:47 | 只看該作者
13#
發(fā)表于 2025-3-23 20:13:44 | 只看該作者
14#
發(fā)表于 2025-3-24 01:59:18 | 只看該作者
th renal cancer having localized or advanced disease are discussed. Surgical approaches for primary and metastatic tumors, symptom palliation, and systemic therapy for metastatic disease including immunotherapy and targeted approaches are discussed in detail..978-1-60761-469-2978-1-60327-149-3
15#
發(fā)表于 2025-3-24 05:41:00 | 只看該作者
https://doi.org/10.1007/978-3-642-88120-6s and experimental studies. Furthermore, pathologists could allocate any redundant tumor tissues not required for diagnosis to basic research programs. Pathologists, urologists, and other clinicians play equally important roles in the optimal handling and processing of renal cell carcinoma specimens.
16#
發(fā)表于 2025-3-24 09:32:14 | 只看該作者
17#
發(fā)表于 2025-3-24 14:14:06 | 只看該作者
Probleme der Sch?deldachplastikradiologic data will be of importance to validate results if a surrogate endpoint such as disease free survival is utilized. In view of our current knowledge of the biology of clear cell carcinoma, studies utiling medications such as sunitinib, sorafenib, or bevacizumab are considerations.
18#
發(fā)表于 2025-3-24 18:17:02 | 只看該作者
19#
發(fā)表于 2025-3-24 20:11:09 | 只看該作者
20#
發(fā)表于 2025-3-25 01:57:43 | 只看該作者
Adjuvant Therapy of Renal Cell Carcinoma,radiologic data will be of importance to validate results if a surrogate endpoint such as disease free survival is utilized. In view of our current knowledge of the biology of clear cell carcinoma, studies utiling medications such as sunitinib, sorafenib, or bevacizumab are considerations.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 01:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
丰都县| 甘泉县| 水城县| 商洛市| 靖远县| 陆河县| 新蔡县| 裕民县| 安龙县| 长武县| 兴和县| 南宁市| 正宁县| 绥化市| 将乐县| 略阳县| 武川县| 惠水县| 修文县| 霍邱县| 禹州市| 庆城县| 梅州市| 阜阳市| 衢州市| 广宗县| 繁昌县| 横峰县| 罗源县| 凤冈县| 海门市| 江华| 龙山县| 拉萨市| 海兴县| 龙门县| 神池县| 凌云县| 介休市| 孟村| 龙山县|